Linked Life Data

12389876

Source:http://linkedlifedata.com/resource/pubmed/id/12389876

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2002-10-22
pubmed:abstractText
To review the pharmacology, pharmacokinetics, efficacy, safety, and drug-drug and drug-food interactions of imatinib and the economic considerations of imatinib in the treatment of chronic myeloid leukemia (CML).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0277-0008
pubmed:author
pubmed:issnType
Print
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1249-65
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Imatinib mesylate, the first molecularly targeted gene suppressor.
pubmed:affiliation
Pharmacy Care Management, Henry Ford Health System, Detroit, Michigan, USA.
pubmed:publicationType
Journal Article, Comparative Study, Review